loader2
Partner With Us NRI

Torrent Pharmaceuticals Ltd share Price

Company details

1,795.60
1,822.00
1,359.20
1,884.90
6M Return 11.20%
1Y Return 28.31%
Mkt Cap.(Cr) 61,121.47
Volume 264,778
Div Yield 1.22%
OI
-
OI Chg %
-
Volume 264,778
NSE

Open Free Trading Account Online with ICICIDIRECT

Branded business continues to influence numbers…

About The Stock

    Incorporated in 1959, Torrent has a strong presence in domestic and semi-regulated markets and a growing presence in regulated markets.

    • Revenues – India including CRAMs (57%), Brazil (9%), US (13%) and Germany (11%)
    • Torrent is the eighth largest domestic player and is ranked in top 10 for CVS, CNS, V&M, GI and anti-diabetes therapies in India

Q4FY22

    Growth in revenues boosted by branded portfolio.

    • Sales were up 10% YoY to ₹ 2131 crore
    • EBITDA was at ₹ 561 crore, down 4% YoY with margins at 26.3%
    • Adjusted PAT was at ₹ 540 crore (up 67% YoY) [note: Profit is adjusted for one-time loss for impairment provision for discontinuance of liquids business in US for ₹ 485 crore]

Click here for full recommendation

Research view on more stocks

Torrent Pharmaceuticals Ltd.

Q4FY23 Quarterly & FY23 Annual Result Announced for Torrent Pharmaceuticals Ltd.

Torrent Pharmaceuticals announced Q4FY23 results:

  • Q4FY23:
    • Revenue at Rs 2,491 crore up by 17%
    • Gross margins: 72%; Op. EBITDA margins: 29.2%
    • Op. EBITDA at Rs 727 crore was up by 30%
    • Profit after tax at Rs 287 crore
  • FY23:
    • Revenue at Rs 9,620 crore up by 13%
    • Gross margins: 71%; Op. EBITDA margins: 29%
    • Op. EBITDA at Rs 2,842 crore was up by 17%
    • Profit after tax at Rs 1,245 crore

 

 

Result PDF

View Other Company Results

OUR RESEARCH VIEW

Investment recommendation

Branded business continues to influence numbers…
Call Date
27 Jan 2023
Entry Price 1,557.00
Target Price 1,720.00
Duration
12-18 Month
HOLD View Report
DISCOVER MORE

FINANCIALS

Sales
Operating Profit
Profit after Tax
DISCOVER MORE
Equity
Reserves and Surplus
Debt
DISCOVER MORE
Sales
Operating Profit
Profit after Tax
DISCOVER MORE
PE
Debt/Equity
P BV
DISCOVER MORE

Torrent Pharmaceuticals Ltd Stocks COMPARISION

DISCOVER MORE

INSIDER & INSTITUIONAL ACTIVITY

Equity Capital: 5,952.95 Cr FV: 5.00

Period MF Net Purchase / (sold) FII Net
LAST 1M 7,434.08 30,851.81
LAST 3M 18,139.88 59,059.53
LAST 6M 65,342.23 45,150.76
LAST 12M 117,520.45 98,037.67

Torrent Pharmaceuticals Ltd Information

Stock PE (TTM)
49.11
Promoter Holding
71.25%
Book Value
183.138
ROCE
18.2%
ROE
18.26%
Registered Address

Torrent House, Off Ashram Road, Ahmedabad, Gujarat, 380009

Tel : 91-79-26599000
Email : investorservices:torrentpharma.com
Website : http://www.torrentpharma.com
Registrar

Karvy Computershare Pvt Ltd

AGM Date (Month) : Jul
Face Value Equity Shares : 5
Market Lot Equity Shares : 1
BSE Code : 500420
NSE Code : TORNTPHARM
Book Closure Date (Month) :
BSE Group : A
ISIN : INE685A01028

FAQ’s on Torrent Pharmaceuticals Ltd Shares

You can buy Torrent Pharmaceuticals Ltd shares through a brokerage firm. ICICIdirect is a registered broker through which you can place orders to buy Torrent Pharmaceuticals Ltd Share.

Company share prices and volatile and keep changing according to the market conditions. As of Jun 09, 2023 03:51 PM the closing price of Torrent Pharmaceuticals Ltd was ₹ 1,805.95.

Market capitalization or market cap is determined by multiplying the current market price of a company’s shares with the total number of shares outstanding. As of Jun 09, 2023 03:51 PM, the market cap of Torrent Pharmaceuticals Ltd stood at ₹ 61,121.47.

The latest PE ratio of Torrent Pharmaceuticals Ltd as of Jun 09, 2023 03:51 PM is 49.11

The latest PB ratio of Torrent Pharmaceuticals Ltd as of Jun 09, 2023 03:51 PM is 0.10

The 52-week high of Torrent Pharmaceuticals Ltd is ₹ 1,884.90 while the 52-week low is ₹ 1,359.20

According to analyst recommendations, Torrent Pharmaceuticals Ltd has a “Buy” rating for the long term.

Download Our App

market app
market app